Article

Prognostic Significance of STC2 and DNA methylation in Head and Neck Squamous Cell Carcinoma: A Study Based on the TCGA and GEO Databases

2021-02-12

Abstract excerpt

<h4>Background: </h4> Head and neck squamous cell carcinoma (HNSC) is a popular malignancy type that brings about poor prognosis with a low survival rate worldwide. Stanniocalcin 2 (STC2) is a glycosylated peptide hormone and shows the potential to become a new biomarker for the evaluation of malignant tumors. The purpose of this study was to explore the prognostic implications of STC2 and DNA methylation in HNSC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 94235477-10af-562c-a306-10d530d4f78b
DOI: 10.21203/rs.3.rs-191202/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic Significance of STC2 and DNA methylation in Head and Neck Squamous Cell Carcinoma: A Study Based on the TCGA and GEO DatabasesDOI 10.21203/rs.3.rs-191202/v1Read

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)Semantic proximity Read

The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinomaSemantic proximity Read

A Novel Four-CpG Prognostic Risk Score Model Predicts Survival and Guides Therapy in Patients with Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Clinical characterization and immune regulation of IL17C in head and neck squamous cell carcinoma through 431 samplesSemantic proximity Read

Identification of Potential Prognostic Biomarkers for Tongue Squamous Cell CarcinomaSemantic proximity Read

A 8-gene-methylation-based Signature for Head and Neck Squamous Cell Carcinoma PrognosisSemantic proximity Read

Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinomaSemantic proximity Read

Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistanceSemantic proximity Read

Identification of SHC2 as a prognostic biomarker: from pan-cancer analysis to colon adenocarcinoma validationSemantic proximity Read

Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistanceSemantic proximity Read

TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosisSemantic proximity Read

Multimodal genomic markers predict immunotherapy response in the head and neck squamous cell carcinomaSemantic proximity Read